Keywords: Testosterone replacement therapy, Datamonitor, Eli Lilly, Axiron

Market development key for testosterone replacement therapy, set to be a $1.4 billion market in 2019

Article | 17 November 2010

Print This

Despite growing at a compound annual growth rate of more than 24% over the last five years, the testosterone replacement therapy ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in